Latest news
LISATA THERAPEUTICS, INC. 2026: Revenue $0 EPS ($0.32) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTLisata Therapeutics Files Suit Against Kuva Labs, Reviews Strategic Alternatives and Cuts Workforce to Preserve Cash - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:15:00 GMT